Literature DB >> 16751605

The effects of sodium sulfate, glycosaminoglycans, and Congo red on the structure, stability, and amyloid formation of an immunoglobulin light-chain protein.

Richard W McLaughlin1, Janelle K De Stigter, Laura A Sikkink, Elizabeth M Baden, Marina Ramirez-Alvarado.   

Abstract

Light-chain amyloidosis (AL) is characterized by immunoglobulin light-chain fragments aggregating into amyloid fibrils that deposit extracellularly in vital organs such as the kidney, the heart, and the liver, resulting in tissue degeneration and organ failure, leading to death. Cardiac involvement is found in 50% of AL patients and presents the most severe cases with a life expectancy of less than a year after diagnosis. In this study, we have characterized the variable domain of a cardiac AL patient light chain called AL-09. AL-09 folds as a beta-sheet and is capable of forming amyloid fibrils both in the presence of sodium sulfate and in self-seeded reactions under physiological conditions. Glycosaminoglycans such as dermatan sulfate and heparin promote amyloid formation of self-seeded AL-09 reactions, while the glycosaminoglycan chondroitin sulfate A stabilized oligomeric intermediates and did not elongate the preformed fibrils (nucleus) present in the reaction. Finally, the histological dye Congo red, known to bind to the cross beta-sheet structure of amyloid fibrils, inhibits AL-09 amyloid fibril formation in the presence of sodium sulfate and in self-seeded reactions. This paper provides insight into the impact of different reagents on light-chain stability, structure, amyloid fibril formation, and inhibition.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16751605      PMCID: PMC2242560          DOI: 10.1110/ps.051997606

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  44 in total

1.  Transfer amyloidosis.

Authors:  F Hardt; P Ranlov
Journal:  Int Rev Exp Pathol       Date:  1976

2.  Mutations in the B1 domain of protein G that delay the onset of amyloid fibril formation in vitro.

Authors:  Marina Ramírez-Alvarado; Melanie J Cocco; Lynne Regan
Journal:  Protein Sci       Date:  2003-03       Impact factor: 6.725

Review 3.  Functional structure and composition of the extracellular matrix.

Authors:  Fred T Bosman; Ivan Stamenkovic
Journal:  J Pathol       Date:  2003-07       Impact factor: 7.996

4.  Further characterization of amyloid-enhancing factor.

Authors:  M A Axelrad; R Kisilevsky; J Willmer; S J Chen; M Skinner
Journal:  Lab Invest       Date:  1982-08       Impact factor: 5.662

Review 5.  Amyloidogenesis: historical and modern observations point to heparan sulfate proteoglycans as a major culprit.

Authors:  John B Ancsin
Journal:  Amyloid       Date:  2003-06       Impact factor: 7.141

Review 6.  Apolipoprotein E, amyloid, and Alzheimer disease.

Authors:  K R Bales; J C Dodart; R B DeMattos; D M Holtzman; S M Paul
Journal:  Mol Interv       Date:  2002-10

Review 7.  Diseases of protein conformation: what do in vitro experiments tell us about in vivo diseases?

Authors:  Joel N Buxbaum
Journal:  Trends Biochem Sci       Date:  2003-11       Impact factor: 13.807

8.  The effect of macromolecular crowding on protein aggregation and amyloid fibril formation.

Authors:  Larissa A Munishkina; Elisa M Cooper; Vladimir N Uversky; Anthony L Fink
Journal:  J Mol Recognit       Date:  2004 Sep-Oct       Impact factor: 2.137

9.  Congo red populates partially unfolded states of an amyloidogenic protein to enhance aggregation and amyloid fibril formation.

Authors:  Yong-Sung Kim; Theodore W Randolph; Mark C Manning; Fred J Stevens; John F Carpenter
Journal:  J Biol Chem       Date:  2003-01-15       Impact factor: 5.157

10.  Inhibition of amyloid A amyloidogenesis in vivo and in tissue culture by 4-deoxy analogues of peracetylated 2-acetamido-2-deoxy-alpha- and beta-d-glucose: implications for the treatment of various amyloidoses.

Authors:  Robert Kisilevsky; Walter A Szarek; John B Ancsin; Elena Elimova; Sandra Marone; Shridhar Bhat; Ali Berkin
Journal:  Am J Pathol       Date:  2004-06       Impact factor: 4.307

View more
  40 in total

1.  Sulfated glycosaminoglycans accelerate transthyretin amyloidogenesis by quaternary structural conversion.

Authors:  Steve Bourgault; James P Solomon; Natàlia Reixach; Jeffery W Kelly
Journal:  Biochemistry       Date:  2011-01-24       Impact factor: 3.162

2.  Comparison of amyloid fibril formation by two closely related immunoglobulin light chain variable domains.

Authors:  Douglas J Martin; Marina Ramirez-Alvarado
Journal:  Amyloid       Date:  2010-09       Impact factor: 7.141

3.  Mutations can cause light chains to be too stable or too unstable to form amyloid fibrils.

Authors:  Marta Marin-Argany; Jofre Güell-Bosch; Luis M Blancas-Mejía; Sandra Villegas; Marina Ramirez-Alvarado
Journal:  Protein Sci       Date:  2015-09-07       Impact factor: 6.725

Review 4.  Sulfated glycosaminoglycans in protein aggregation diseases.

Authors:  Kazuchika Nishitsuji; Kenji Uchimura
Journal:  Glycoconj J       Date:  2017-04-11       Impact factor: 2.916

5.  Role of glycosaminoglycan sulfation in the formation of immunoglobulin light chain amyloid oligomers and fibrils.

Authors:  Ruiyi Ren; Zhenning Hong; Haiyan Gong; Kate Laporte; Martha Skinner; David C Seldin; Catherine E Costello; Lawreen H Connors; Vickery Trinkaus-Randall
Journal:  J Biol Chem       Date:  2010-09-24       Impact factor: 5.157

6.  Altered dimer interface decreases stability in an amyloidogenic protein.

Authors:  Elizabeth M Baden; Barbara A L Owen; Francis C Peterson; Brian F Volkman; Marina Ramirez-Alvarado; James R Thompson
Journal:  J Biol Chem       Date:  2008-04-08       Impact factor: 5.157

7.  Structural insights into the role of mutations in amyloidogenesis.

Authors:  Elizabeth M Baden; Edward G Randles; Awo K Aboagye; James R Thompson; Marina Ramirez-Alvarado
Journal:  J Biol Chem       Date:  2008-09-02       Impact factor: 5.157

8.  Salts enhance both protein stability and amyloid formation of an immunoglobulin light chain.

Authors:  Laura A Sikkink; Marina Ramirez-Alvarado
Journal:  Biophys Chem       Date:  2008-03-18       Impact factor: 2.352

9.  Biologic and genetic characterization of the novel amyloidogenic lambda light chain-secreting human cell lines, ALMC-1 and ALMC-2.

Authors:  Bonnie K Arendt; Marina Ramirez-Alvarado; Laura A Sikkink; Jonathan J Keats; Gregory J Ahmann; Angela Dispenzieri; Rafael Fonseca; Rhett P Ketterling; Ryan A Knudson; Erin M Mulvihill; Renee C Tschumper; Xiaosheng Wu; Steven R Zeldenrust; Diane F Jelinek
Journal:  Blood       Date:  2008-06-20       Impact factor: 22.113

10.  The Kinetic Stability of a Full-Length Antibody Light Chain Dimer Determines whether Endoproteolysis Can Release Amyloidogenic Variable Domains.

Authors:  Gareth J Morgan; Jeffery W Kelly
Journal:  J Mol Biol       Date:  2016-08-26       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.